"Heart disease is the leading cause of death for both men and women, but heart disease is preventable and controllable.
Every journey begins with one step, whether it's climbing a mountain or preventing heart disease. This American Heart"...
Because thrombolytic therapy increases the risk of bleeding, Retavase® (reteplase) is contraindicated in the following situations:
- Active internal bleeding
- History of cerebrovascular accident
- Recent intracranial or intraspinal
- Intracranial neoplasm, arteriovenous
- Known bleeding diathesis
- Severe uncontrolled hypertension
Last reviewed on RxList: 9/15/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Retavase Information
Report Problems to the Food and Drug Administration
Get the latest treatment options.